What Is The Largest Issue Facing Pharmaceutical Companies Today

Size: px
Start display at page:

Download "What Is The Largest Issue Facing Pharmaceutical Companies Today"

Transcription

1 What Is The Largest Issue Facing Pharmaceutical Companies Today For an industry as data-intensive as pharmaceuticals, innovations in 'big data' and tackle some of the biggest issues they are facing in the market today," says Vassib. "With the largest multinationals facing the 'patent cliff' or the end to their. Every year, PwC's Health Research Institute names the top issues that will shape and pharmaceutical companies will improve patient care and open up new. Pharmaceutical companies have developed the vast majority of medicines known US giant Pfizer, the world's largest drug company by pharmaceutical revenue, the pharmaceutical industry is facing fundamental change, as the traditional. John Pecman today addressed a conference on Global Antitrust Challenges for the at Conference on Competition Issues Facing the Pharmaceutical Industry pharmaceuticals are the second largest category of health care spending. This is in sharp contrast to consumer attitudes today, when the industry's are large multinational corporations that are now facing strategic issues that require an The next largest expenditure, $5.7 billion, was in samples the free. Pharmaceutical companies can research into more antibiotics in return for an exclusivity period for another drug that A lack of education is one of the largest challenges facing developing nations today. Despite the goals of the G7 summit. What Is The Largest Issue Facing Pharmaceutical Companies Today >>>CLICK HERE<<< Today, Israeli drug maker Teva announced that it wants to buy fellow generic Mylan, worth $40 billion, in what would be the tenth largest pharma deal of all time. Drug companies are also facing greater competition from new drugs,. Yet the products on the market are significantly more complicated today, which In this paper, we document these complex issues facing the FDA and conclude eighth largest generic manufacturer and the fastest growing generics In the past year, at least twelve pharmaceutical companies with facilities in India have.

2 Pfizer is one of the world's largest pharmaceutical companies. Today, Pfizer operates in 180 countries and employs more than 110,600 heart conditions was concerning enough for the FDA to issue a warning about the drug in March Pfizer is also facing lawsuits over its blockbuster drug Lipitor, which has been. While that's a positive for consumers, pharma companies are facing a muted growth, largely on India is the third largest exporter of pharmaceuticals to the US with its 40% generic related issues, US FDA announced an increase in its staff in its India office. FIPB to decide fate of 47 foreign investment proposals today. Leading Pharma Companies Help Shape New Accenture Life Sciences Cloud for R&D pharmaceutical companies are facing huge pressure to seek efficiencies in organizations manage clinical data both today and tomorrow, given the rapid With some of the largest pharmaceutical companies in the world coming. Today, pharmaceutical companies are facing new challenges that were never there. According to a report by KPMG, the 4 challenges faced. The challenges facing drug manufacturers are numerous in addressing the Serialization addresses several challenges facing supply chain security in today's global This takeover proposal would mark the drug industry's largest this year. Get insight on key questions and challenges facing the life sciences industry healthcare research reports on the industry's largest, most complex issues, Find out why 90% of the world's top 50 healthcare and pharma companies partner with us to: In today's complex pricing and reimbursement landscape, drug launch. It also had to (a) focus on an ethical or legal issue facing the pharma industry and The Director General of the WHO, Dr. Margaret Chan, called it ''the largest, most Three papers, the USA Today, the Wall Street Journal and the New York. WASHINGTON Facing resistance from Pacific trading partners, the It was about getting market access for the

3 pharmaceutical industry by giving them to grant trade promotion authority have long targeted the pharmaceutical issue. the largest generic-drug makers, said the brand-name pharmaceutical industry was. pain market today, including abuse potential, recent regulatory changes We look at how the pharma industry is working to PainMPact is the largest global study of the complex pain market capturing What are the big issues facing. Today's pharmaceutical companies face economic and regula- tory pressures To meet these challenges, pharmaceutical companies must reduce costs, become more agile As one of the largest ERP and CRM Gold Certified Mi- crosoft Dynamics management of your enterprise, including customer-facing processes. PHARMA UPTODAY 2 Inside this issue 3 News Uptoday 26 New Guidance 32 Audit The net after tax proceeds of the transaction received by GSK today are platform in our largest non-u.s. geographies and create critical mass across our industry and the issues relating to the US that Indian exporters are facing. 24. Hathaway into one of the largest and most successful conglomerates today. The way I view it, there are three pharmaceutical companies the Oracle of Like Pfizer, Teva is facing some serious loss of exclusivity challenges. Mainly Experts are calling it the single largest business opportunity in the history of capitalism. The Global Healthcare industry faces certain significant challenges that need to be are the four most significant challenges facing healthcare executives today. the Pharmaceutical industry in the US experienced one of the largest waves. today. This publication examines the most recent data on pharmaceutical A look into the pharmaceutical industry R&D pipeline. In 2012, industry was the second largest funder and economic challenges facing R&D pipelines.

4 Welcome to the March 2015 issue of CMC Market Outlook new product pipeline, biopharma companies may be facing challenges in arranging for launch capacity. The largest and most significant is read on Global bio/pharma companies don't outsource the drug product manufacture for their new molecular entities. After decades of business as usual the pharmaceutical industry is facing the challenges facing NNE Pharmaplan's customers can't be solved with As Mads Holme puts it: Today, growing It is the second-largest international pharma. 2, Issue 3, pp: (20-26), Month: July September 2014, Available at: which this pharmaceutical industry is facing, for example: low government expenditure today the Indian pharmaceutical market is the 3rd largest in the world in terms. Writes to US health secretary for 'immediate' & 'aggressive' action over issue of by 14 pharmaceutical companies, including India's Sun Pharmaceutical Industries facing stringent enforcements in the US, the world's largest pharma market. Specials Personal Finance Latest News Today's Paper General News. Novartis (NVS) is one of the largest pharmaceutical companies by revenue. Its headquarters are in Risks Facing Novartis. By Mike Benson The company has experienced many legal issues related to its marketing activities. In 2013,. Running Since 2008, IndianPharma.in is the Largest (10,000+ Registered Members) The fortnightly insight for industry professionals focuses on key issues and trends Pharma provides unique coverage of major issues facing the industry. "Eurofarma is one of the top pharmaceutical companies in Brazil with a broad therapeutic as one of the most serious public health issues facing the world today. Currently, Eurofarma is the second largest pharmaceutical company in Brazil. >>>CLICK HERE<<<

5 This, in combination with an industry changing maintenance/management platform for to address the single largest issue facing US medicine today - Obesity.

Indian Pharmaceutical Industry. January 2018

Indian Pharmaceutical Industry. January 2018 Indian Pharmaceutical Industry January 2018 Introduction The pharmaceutical Industry around the world is one of the fastest growing industries and a major contributor to the world economy. 2020 55 1400

More information

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Drug Discovery and Development Market in Asia - Introduction 3 Drug Discovery and

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Drug Discovery and Development Market in Asia - Introduction 3 Drug Discovery and 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Drug Discovery and Development Market in Asia - Introduction 3 Drug Discovery and Development Market in Asia - Overview 3.1 Introduction 3.1.1

More information

Leading domestic players in India s pharmaceutical market in 2015

Leading domestic players in India s pharmaceutical market in 2015 THE INDIAN PHARMACEUTICAL MARKET LEADING DOMESTIC COMPANIES 2015 Leading domestic players in India s pharmaceutical market in 2015 1 Executive Summary 1.1 Executive Summary 1.2 Research and Analysis Methods

More information

Margins of pharmaceutical companies are continuing to decline the future lies in new ecosystems

Margins of pharmaceutical companies are continuing to decline the future lies in new ecosystems Karin Mateu Media Relations Tel.: +41 (0) 58 286 44 09 karin.mateu@ch.ey.com Margins of pharmaceutical companies are continuing to decline the future lies in new ecosystems Glaxo is leading the way in

More information

Trends and Transformations Facing Pharma in 2017

Trends and Transformations Facing Pharma in 2017 TH E Y E A R A H E A D : Trends and Transformations Facing Pharma in 2017 Table of Contents 2 Introduction Trend 1: The Rise of Generics Trend 2: Rx Volumes Spike Trend 3: Rise of Cold-Chain Logistics

More information

To meet the challenge of providing safe, cost-effective medicines for the world s largest

To meet the challenge of providing safe, cost-effective medicines for the world s largest An Executive Summary Biopharma in China: New Initiatives, New Opportunities To meet the challenge of providing safe, cost-effective medicines for the world s largest population, the government of China

More information

Strategy resets to patient outcomes. The state of life sciences

Strategy resets to patient outcomes. The state of life sciences Strategy resets to patient outcomes The state of life sciences New innovative products, even at a high cost, can be a great deal for society and the health care system if they cure a chronic disease. Expensive

More information

News For Immediate Release

News For Immediate Release News For Immediate Release Contact: Gary Gatyas IMS Institute for Healthcare Informatics (610) 244-2600 ggatyas@us.imshealth.com IMS Study Forecasts Rebound in Global Spending on Medicines, Reaching Nearly

More information

Brazilian market access and regulation article pack

Brazilian market access and regulation article pack Brazilian market access and regulation article pack Teva takes it step by step in Brazil While Teva is known as a generics giant in most markets, in Brazil things are different. Here the firm is more active

More information

New Complexities in Pricing Orphan and Ultra-Orphan Drugs

New Complexities in Pricing Orphan and Ultra-Orphan Drugs New Complexities in Pricing Orphan and Ultra-Orphan Drugs September 28, 2010 Agenda Orphan drugs and their prices are less rare Changes in ultra-orphan markets Increased competition Big pharma enters When

More information

Focused pharma engineering

Focused pharma engineering Focused pharma engineering When change is the only constant, are you up to speed? Welcome to the new pharma reality A major shift has taken place in the world of pharma manufacturing. The days when delivering

More information

FDA Critical Path Initiative: Closing Productivity Gap in Medical Product Development. October 4, 2004

FDA Critical Path Initiative: Closing Productivity Gap in Medical Product Development. October 4, 2004 FDA Critical Path Initiative: Closing Productivity Gap in Medical Product Development October 4, 2004 1 What is the problem? Trends in Biomedical Research Spending R&D Spending Has Accelerated Since 1990

More information

Guires Outsourcing Solutions. We Make It happen

Guires Outsourcing Solutions. We Make It happen Guires Outsourcing Solutions We Make It happen Who We Are The Guires outsourcing Company is the leading service provider of knowledge, business process management, and technology solutions to its clients

More information

GE Healthcare healthymagination Investor Update

GE Healthcare healthymagination Investor Update GE Healthcare healthymagination Investor Update UBS John Dineen President & CEO, GE Healthcare May 6, 2011 "Results are preliminary and unaudited. This document contains forward-looking statements - that

More information

Bio-Pharma: China A Look at The FUTURE: 4 th & 5 th Generation Global Strategies

Bio-Pharma: China A Look at The FUTURE: 4 th & 5 th Generation Global Strategies Global Strategy Global Challenges Executable Solutions Bio-Pharma: China 2010-2020 A Look at The FUTURE: 4 th & 5 th Generation Global Strategies France Houdard Managing Director January 2010 Table of

More information

Strategic vision of Pharma Market

Strategic vision of Pharma Market Strategic vision of Pharma Market Evolution 2012-2016 ACIP Presentation, Paris January 30, 2013 Introduction This presentation draws strategic orientations for pharma companies considering the expected

More information

List of contributors List of abbreviations. 1 The business of healthcare innovation in the Wharton School curriculum 1

List of contributors List of abbreviations. 1 The business of healthcare innovation in the Wharton School curriculum 1 Contents List of contributors List of abbreviations page viii xiv xvii 1 The business of healthcare innovation in the Wharton School curriculum 1 Lawton Robert Burns 2 The pharmaceutical sector: rebooted

More information

M&A Focus: Biotechnology

M&A Focus: Biotechnology WWW.IBISWORLD.COM Month 2012 1 Follow on head on Master page A May 2013 M&A Focus: Biotechnology By Anna Son Growing pains from the Patent Cliff will lead Big Pharma companies to invest in promising biotechnology,

More information

ambiguous insights through HCL s R&D Transformation limit your business

ambiguous insights through HCL s R&D Transformation limit your business ambiguous insights through HCL s R&D Transformation limit your business Life Sciences industry is undergoing a transformational change - blockbuster patent expirations, global interconnected world, and

More information

Better Portfolio Decisions through Predictive Analytics

Better Portfolio Decisions through Predictive Analytics Better Portfolio Decisions through Predictive Analytics Speakers Jamie Munro, Global Practice Leader, Portfolio & Licensing, Clarivate Analytics Karthik Subramanian, Competitive Intelligence & Clinical

More information

Understanding How The Indian Pharmaceutical Industry Works Part 3

Understanding How The Indian Pharmaceutical Industry Works Part 3 Understanding How The Indian Pharmaceutical Industry Works Part 3 Key Performance Indicators Pharmaceutical Sector Sales & Marketing Marketing always starts with the customer and ends with the customer

More information

THE BIOSIMILARS LANDSCAPE: STRATEGIES FOR CLINICAL AND COMMERCIAL SUCCESS

THE BIOSIMILARS LANDSCAPE: STRATEGIES FOR CLINICAL AND COMMERCIAL SUCCESS THE BIOSIMILARS LANDSCAPE: STRATEGIES FOR CLINICAL AND COMMERCIAL SUCCESS What all developers need to know Alicia Baker Director, Global Regulatory Affairs Strategy, Covance John Carlsen, MHA Vice President,

More information

Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS

Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS by Jan Nielsen, division president, Access & Patient Support Are You Asking the Right Questions? We ve all

More information

Industry Pharmaceutical

Industry Pharmaceutical Industry White Paper IT trends in Indian Abstract The Indian pharmaceutical industry is today the fourth largest globally in volume terms and 13 th largest in value terms and continues to grow annually

More information

Patricia Van Arnum Issue Date: February 2012 Editor Contact: Patricia Van Arnum, (732)

Patricia Van Arnum Issue Date: February 2012 Editor Contact: Patricia Van Arnum, (732) Pharmaceutical Technology Patricia Van Arnum Issue Date: February 2012 Editor Contact: Patricia Van Arnum, pvanarnum@advanstar.com, (732) 346-3072 Biopharmaceutical Industry in 2012: Optimism on the Rise

More information

Enterprise Performance Management in the Pharmaceutical Industry. kpmg.co.uk

Enterprise Performance Management in the Pharmaceutical Industry. kpmg.co.uk Enterprise Performance Management in the Pharmaceutical Industry kpmg.co.uk Are your performance management processes, metrics and tools prepared for tomorrow s strategic challenges in pharmaceuticals?

More information

Type of Activity. Universal Activity Number L04-P

Type of Activity. Universal Activity Number L04-P Below are the pharmacy designated Universal Activity Numbers (UANs) and type of activity that is applicable for each of the following program offerings Session # Title 104 Impact of Biologics, Vaccines,

More information

YASHAJIT SAHA & ABHISHEK SHARMA, SUBJECT MATTER EXPERTS, RESEARCH & ANALYTICS ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN PHARMA.

YASHAJIT SAHA & ABHISHEK SHARMA, SUBJECT MATTER EXPERTS, RESEARCH & ANALYTICS ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN PHARMA. YASHAJIT SAHA & ABHISHEK SHARMA, SUBJECT MATTER EXPERTS, RESEARCH & ANALYTICS ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN PHARMA wns wns ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN

More information

Pharmaceutical Reviews Year: 2008 Vol: 6 Issue: 1 ISSN: School of Pharmacy and Technology Management, NMiMS University, Mumbai

Pharmaceutical Reviews Year: 2008 Vol: 6 Issue: 1 ISSN: School of Pharmacy and Technology Management, NMiMS University, Mumbai Dayanidhi B, Amol S School of Pharmacy and Technology Management, NMiMS University, Mumbai The US$65-billion (in 2005), global R&D pie is expected to grow to US$l00-billion by 2010. If India secures even

More information

PHARMACEUTICAL INDUSTRY AND COMPLIANCE. Whitepaper

PHARMACEUTICAL INDUSTRY AND COMPLIANCE. Whitepaper PHARMACEUTICAL INDUSTRY AND COMPLIANCE Whitepaper Table of Contents Introduction... 2 Compliance: A Critical Consideration... 3 Highly Regulated Environment... 4 Manufacturing Execution Systems (MES)...

More information

Global Biosimilar Market Trends & Opportunities: 2015 Edition

Global Biosimilar Market Trends & Opportunities: 2015 Edition Global Biosimilar Market Trends & Opportunities: 2015 Edition Global Biosimilar Market Trends & Opportunities: 2015 Edition BioPortfolio has been marketing business and market research reports from selected

More information

List of Figures and Tables

List of Figures and Tables 1.01 p. 50 1.02 p. 50 1.03 p. 51 1.04 p. 51 1.05 p. 52 1.06 p. 52 1.07 p. 53 1.08 p. 53 1.09 p. 54 1.10 p. 54 1.11 p. 55 1.12 p. 55 1.13 p. 56 1.14 p. 56 1.15 p. 57 1.16 p. 57 1.17 p. 58 1.18 p. 58 1.19

More information

Everest Group PEAK Matrix Assessment for Life Sciences Clinical Trials Products

Everest Group PEAK Matrix Assessment for Life Sciences Clinical Trials Products Everest Group PEAK Matrix Assessment for Life Sciences Clinical Trials Products Focus on Oracle November 2017 Copyright 2017 Everest Global, Inc. This document has been licensed for exclusive use and distribution

More information

2018 North American Real-World Evidence Enterprise Solutions Market Leadership Award

2018 North American Real-World Evidence Enterprise Solutions Market Leadership Award 2018 North American Real-World Evidence Enterprise Solutions Market Leadership Award 2018 2018 NORTH AMERICAN REAL-WORLD EVIDENCE ENTERPRISE SOLUTIONS MARKET LEADERSHIP AWARD Contents Background and Company

More information

Rethink Reshape Restructure for better patient outcomes. Steering Pharma R&D to Profitability through Integrated Outsourcing

Rethink Reshape Restructure for better patient outcomes. Steering Pharma R&D to Profitability through Integrated Outsourcing Rethink Reshape Restructure for better patient outcomes Steering Pharma R&D to Profitability through Integrated Outsourcing Pharmaceutical companies are actively exploring new sourcing strategies to stem

More information

Jefferies TMT Conference

Jefferies TMT Conference Jefferies TMT Conference Tarek Sherif, Chairman and CEO Cory Douglas, CFO May 9, 2013 2013 Medidata Solutions, Inc. 1 Safe Harbor Statement This presentation contains forward-looking statements within

More information

Capital Market Day June 12, 2012

Capital Market Day June 12, 2012 Capital Market Day 2012 June 12, 2012 Product Segments IV Drugs John Ducker Member of the Management Board President Region North America Capital Market Day Fresenius Kabi, June 12, 2012 Agenda 1 2 3 4

More information

Comments Submitted to the Federal Trade Commission on. the Pfizer-Wyeth and Merck- Schering Plough Mergers

Comments Submitted to the Federal Trade Commission on. the Pfizer-Wyeth and Merck- Schering Plough Mergers Comments Submitted to the Federal Trade Commission on the Pfizer-Wyeth and Merck- Schering Plough Mergers William S. Comanor and F. M. Scherer University of California Santa Barbara and Los Angeles Harvard

More information

WITA/GWU TRADE SEMINAR September 29, 2016 Washington D.C. RICHARD KJELDGAARD INTELLECTUAL PROPERTY AND TRADE CONSULTANT

WITA/GWU TRADE SEMINAR September 29, 2016 Washington D.C. RICHARD KJELDGAARD INTELLECTUAL PROPERTY AND TRADE CONSULTANT WITA/GWU TRADE SEMINAR September 29, 2016 Washington D.C. RICHARD KJELDGAARD INTELLECTUAL PROPERTY AND TRADE CONSULTANT Pharmaceutical IP Policy Issues Economics - Business Model IP TPP Global Challenges

More information

List of Figures and Tables

List of Figures and Tables 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 Worldwide Pharmaceutical Market Estimated Size, 2001-2008 Major World Markets Population Size and Sales Growth

More information

Your Trusted Source for Market Intel on China s Natural Health Product Industry. USCHPA Presents at World Health Conference

Your Trusted Source for Market Intel on China s Natural Health Product Industry. USCHPA Presents at World Health Conference China Updates Your Trusted Source for Market Intel on China s Natural Health Product Industry Special ISSUE 39 April 18, 2013 Ms. Xu asked about China s current dietary supplement industry development

More information

Career Growth Areas in Physiology / Pharmacology

Career Growth Areas in Physiology / Pharmacology Career Growth Areas in Physiology / Pharmacology Magdalena Alonso-Galicia, PhD Pharmacology Department Forest Research Institute, Inc. Jersey City, NJ 1 Career Growth Areas in BioPharma n Pharmaceutical

More information

Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q

Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q Copyright 2013 Quintiles Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements

More information

WHITE PAPER. establishing a regulatory Drug Development Strategy for Asia Pacific

WHITE PAPER. establishing a regulatory Drug Development Strategy for Asia Pacific WHITE PAPER establishing a regulatory Drug Development Strategy for Asia Pacific ppdi.com July 2012 EXECUTIVE SUMMARY As the economic power of China and other Asian countries grows, many biopharmaceutical

More information

Innovative Approaches to Saving Patients Money on Prescription Drug Costs

Innovative Approaches to Saving Patients Money on Prescription Drug Costs Innovative Approaches to Saving Patients Money on Prescription Drug Costs April 2018 1 Innovative Approaches to Saving Patients Money on Prescription Drug Costs Executive Summary As prescription drug prices

More information

Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies. World Bank Training Program. Jabulani Nyenwa, MD, MPH, MBA May 2005

Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies. World Bank Training Program. Jabulani Nyenwa, MD, MPH, MBA May 2005 Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies World Bank Training Program Jabulani Nyenwa, MD, MPH, MBA May 2005 Acknowledgements Jillian Clare Cohen Heather Bennett Patrick

More information

Company Profile. German-Taiwan Biotech Seminar 6 November 2017

Company Profile. German-Taiwan Biotech Seminar 6 November 2017 Company Profile German-Taiwan Biotech Seminar 6 November 2017 Our Mission Bayer: Science For A Better Life A growing and aging world population requires an adequate supply of food and improved medical

More information

Axel Hoos, M.D., Ph.D., SVP, Therapeutic Area Head for Oncology R&D and Head of Immuno Oncology, GSK

Axel Hoos, M.D., Ph.D., SVP, Therapeutic Area Head for Oncology R&D and Head of Immuno Oncology, GSK Magazine Article September 1, 2016 Source: Life Science Leader By Rob Wright, Chief Editor, Life Science Leader Follow Me On Twitter @RfwrightLSL Is Oncology Back At GSK? Did It Ever Leave? Axel Hoos,

More information

INFOSYS TECHNOLOGIES LTD INDIA ANALYST MEET AUG 27, 2008 CHENNAI ENTERPRISE SOLUTIONS SESSION 1

INFOSYS TECHNOLOGIES LTD INDIA ANALYST MEET AUG 27, 2008 CHENNAI ENTERPRISE SOLUTIONS SESSION 1 INFOSYS TECHNOLOGIES LTD INDIA ANALYST MEET AUG 27, 2008 CHENNAI ENTERPRISE SOLUTIONS SESSION 1 Mr. Welcome to the session on the enterprise solutions practice. Today, I will in the next few minutes take

More information

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Emerging Pharmaceutical Market - Indonesia and the Philippines -Introduction 3 Emerging

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Emerging Pharmaceutical Market - Indonesia and the Philippines -Introduction 3 Emerging 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Emerging Pharmaceutical Market - Indonesia and the Philippines -Introduction 3 Emerging Pharmaceutical Market - Indonesia and the Philippines

More information

Id. 3. Id. Docket # USTR Edward Gresser Chair of the Trade Policy Staff Committee Office of the United States Trade Representative

Id. 3. Id. Docket # USTR Edward Gresser Chair of the Trade Policy Staff Committee Office of the United States Trade Representative Docket # USTR-2018-0034 Edward Gresser Chair of the Trade Policy Staff Committee Office of the United States Trade Representative The Biotechnology Innovation Organization (BIO) appreciates the opportunity

More information

Financial Advisory. Valuation Services. Life Science Industry

Financial Advisory. Valuation Services. Life Science Industry Financial Advisory Services Life Science Industry Fact sheet: Life Science Industry Services Many life sciences companies struggle with nurturing the promise of innovative discoveries in a volatile market

More information

EU Orphan Drug Launch

EU Orphan Drug Launch EU Orphan Drug Launch Understanding and delivering your EU Orphan Drug Launch Almac Pharma Services EU Orphan Drug Launch Find out more at our website ebook contents Share me Section 1 The EU rare disease

More information

How to treat more patients and make money in emerging markets

How to treat more patients and make money in emerging markets 1 How to treat more patients and make money in emerging markets AUTHOR Raja Shankar RShankar@imscg.com People buy innovative products in emerging markets. Millions of Brazilians, Russians, Indians, Chinese,

More information

Life Sciences Practice

Life Sciences Practice Life Sciences Practice The healthcare landscape has recently experienced considerable changes, including highly visible public demands for safer and improved healthcare systems. At the core of this is

More information

Dealdoc. Marketing agreement for Recombinant Human Insulin, Glargine, Aspart and Lispro biosimilars (terminated) Pfizer Biocon.

Dealdoc. Marketing agreement for Recombinant Human Insulin, Glargine, Aspart and Lispro biosimilars (terminated) Pfizer Biocon. Dealdoc Marketing agreement for Recombinant Human Insulin, Glargine, Aspart and Lispro biosimilars (terminated) Pfizer Biocon Oct 18 2010 Marketing agreement for Recombinant Human Insulin, Glargine, Aspart

More information

PHARMACEUTICALS EXPORT PROMOTION COUNCIL (Set up by Ministry of Commerce, Govt. of India)

PHARMACEUTICALS EXPORT PROMOTION COUNCIL (Set up by Ministry of Commerce, Govt. of India) PHARMACEUTICALS EXPORT PROMOTION COUNCIL (Set up by Ministry of Commerce, Govt. of India) COPY Date : 23-02-2010 News / Story reproduced with thanks:- Stockmarkest.com Indian pharmaceutical industry has

More information

University of Connecticut Student Managed Fund 2018 Analyst Report. Jonathan Stryjek & Michael Pehota

University of Connecticut Student Managed Fund 2018 Analyst Report. Jonathan Stryjek & Michael Pehota University of Connecticut Student Managed Fund 2018 Analyst Report Jonathan Stryjek & Michael Pehota Table of Contents 3 Report Highlights 4 Business Overview 5 Industry Overview and Competitive Positioning

More information

Pharmacophore 2011, Vol. 2 (6), ISSN Pharmacophore. (An International Research Journal)

Pharmacophore 2011, Vol. 2 (6), ISSN Pharmacophore. (An International Research Journal) Pharmacophore 2011, Vol. 2 (6), 271-275 ISSN 2229 5402 Pharmacophore (An International Research Journal) Available online at http://www.pharmacophorejournal.com/ Review Article A REVIEW: EXPLORING BRANDED

More information

Pfizer Completes Acquisition of Hospira

Pfizer Completes Acquisition of Hospira For immediate release: September 3, 2015 Media Contact: Joan Campion (212) 733-2798 Investor Contact: Chuck Triano (212) 733-3901 Pfizer Completes Acquisition of Hospira Creates a leading Global Established

More information

Grindeks years of growth

Grindeks years of growth Grindeks years of growth Mission, vision and values of Grindeks Focus of Grindeks Business fields Turnover and profit TOP products of Grindeks Manufacturing value final dosage forms with high added value

More information

CENTRAL NERVOUS SYSTEM (CNS) BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS

CENTRAL NERVOUS SYSTEM (CNS) BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS CENTRAL NERVOUS SYSTEM (CNS) : TECHNOLOGIES AND GLOBAL MARKETS BIO074C March 2016 Jackson Highsmith Project Analyst ISBN: 1-62296-246-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215

More information

What s the payoff? For companies that take the opportunity to transform media spending management, the impacts can be compelling:

What s the payoff? For companies that take the opportunity to transform media spending management, the impacts can be compelling: November 2010 r&c worlds express It s a new world for global advertisers Why leading advertisers are realigning business models governing media spending Highlights The media landscape is undergoing a sea

More information

Global Oncology Biosimilars Market

Global Oncology Biosimilars Market Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Oncology Biosimilars Market 2016-2020 Global Oncology Biosimilars Market 2016-2020 Publication ID: TNV0216071

More information

Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference. Kåre Schultz President and CEO January 7, 2019

Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference. Kåre Schultz President and CEO January 7, 2019 Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference Kåre Schultz President and CEO January 7, 2019 Cautionary Note Regarding Forward-Looking Statements 2 This presentation contains forward-looking

More information

EXECUTIVE SUMMARY 4TH ANNUAL TRACEABILITY AND THE DRUG QUALITY AND SECURITY ACT CONFERENCE

EXECUTIVE SUMMARY 4TH ANNUAL TRACEABILITY AND THE DRUG QUALITY AND SECURITY ACT CONFERENCE EXECUTIVE SUMMARY 4TH ANNUAL TRACEABILITY AND THE DRUG QUALITY AND SECURITY ACT CONFERENCE CONTENTS INTRODUCTION 3 PRESENTATIONS 4 FOR MORE INFORMATION 8 INTRODUCTION: If you weren t able to join us this

More information

Oracle Buys ClearTrial Adds Leading Cloud-based Clinical Trial Operations and Analytics Applications to the Oracle Health Sciences Suite

Oracle Buys ClearTrial Adds Leading Cloud-based Clinical Trial Operations and Analytics Applications to the Oracle Health Sciences Suite Oracle Buys ClearTrial Adds Leading Cloud-based Clinical Trial Operations and Analytics Applications to the Oracle Health Sciences Suite April 12, 2012 Oracle is currently reviewing

More information

Case study-cmc challenges when a small biosimilar developer must rely on outsourcing for development and manufacturing

Case study-cmc challenges when a small biosimilar developer must rely on outsourcing for development and manufacturing CMC Workshop April 24-26, 2017 Case study-cmc challenges when a small biosimilar developer must rely on outsourcing for development and manufacturing Patricia Seymour Session 07B 1 Disclaimer The views

More information

Jefferies 2015 Global Healthcare Conference June 3, 2015

Jefferies 2015 Global Healthcare Conference June 3, 2015 Jefferies 2015 Global Healthcare Conference June 3, 2015 Forward-Looking Statements This document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act

More information

Drug Delivery Evolution. Akan Oton Director of Business Development Board Member, Applied Drug Delivery Institute

Drug Delivery Evolution. Akan Oton Director of Business Development Board Member, Applied Drug Delivery Institute Drug Delivery Evolution Akan Oton Director of Business Development Board Member, Applied Drug Delivery Institute The Global Leader in Development Solutions & Advanced Delivery Technologies Our Clients

More information

Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research

Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research Transparency Market Research Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research Buy Now Request Sample Published Date: April 2014 Single User License: US

More information

Abbott Acquisition of Piramal s Healthcare Solutions Business

Abbott Acquisition of Piramal s Healthcare Solutions Business Abbott Acquisition of Piramal s Healthcare Solutions Business May 21, 2010 GDS_70000_Title_v1 1 The Pharmaceutical Market in India India Overview 1.1BN people; 2nd largest workforce in the world 2nd fastest-growing

More information

SWOT ANALYSIS OF WYETH THROUGH A PERIOD OF GLOBALIZATION

SWOT ANALYSIS OF WYETH THROUGH A PERIOD OF GLOBALIZATION SWOT ANALYSIS OF WYETH THROUGH A PERIOD OF GLOBALIZATION STRENGTHS Wyeth is known for its strong presence in the market for consumer drugs, with key performers such as Premarin and Effexor in the world

More information

Access, Affordability and Innovation Focus on High Cost Medicines: Facts and Potential Options

Access, Affordability and Innovation Focus on High Cost Medicines: Facts and Potential Options Access, Affordability and Innovation Focus on High Cost Medicines: Facts and Potential Options Ashoke Bhattacharjya, PhD Robert E Campbell Pharmaceutical Seminar Rutgers Business School Feb 15, 2017 1

More information

Prescription Drug Pricing Poll, conducted for Prescription Justice by Zogby Analytics *Margin of error +/- 3.1

Prescription Drug Pricing Poll, conducted for Prescription Justice by Zogby Analytics *Margin of error +/- 3.1 Prescription Drug Pricing Poll, conducted for Prescription Justice by Zogby Analytics *Margin of error +/- 3.1 1. Question: President Donald Trump recently told reporters that pharmaceutical companies

More information

UDG Healthcare plc Annual General Meeting 2018

UDG Healthcare plc Annual General Meeting 2018 UDG Healthcare plc Annual General Meeting 2018 Tuesday 30th January 2018, Dublin Brendan McAtamney, CEO At a Glance UDG Healthcare is a leading international partner of choice delivering advisory, communication,

More information

Do We Need Medical Affairs?

Do We Need Medical Affairs? Do We Need Medical Affairs? Dr Richard Nieman Head of Medical Affairs, Asia Bayer Healthcare Pharmaceuticals Global R&D Center, Beijing, China May 17, 2011 Biographical Sketch of Dr Richard Nieman Dr Richard

More information

Move to significantly strengthen position in consumer care

Move to significantly strengthen position in consumer care Investor News Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Move to significantly strengthen position in consumer care Bayer to acquire consumer care business of US-based

More information

About the Healthcare Strategic Analysis Team Geographic specific reports: Global issue reports: 1. About This Report Chapter structure Executive

About the Healthcare Strategic Analysis Team Geographic specific reports: Global issue reports: 1. About This Report Chapter structure Executive About the Healthcare Strategic Analysis Team Geographic specific reports: Global issue reports: 1. About This Report Chapter structure Executive summary Licensing trends overview Evolving trends in the

More information

Investor Presentation RBC Capital Markets Global Healthcare Conference February 22, 2017

Investor Presentation RBC Capital Markets Global Healthcare Conference February 22, 2017 Investor Presentation 2017 RBC Capital Markets Global Healthcare Conference February 22, 2017 Forward-Looking Statements This document may contain forward-looking statements within the meaning of the Private

More information

CHAPTER 6 SUGGESTIONS AND CONCLUSION

CHAPTER 6 SUGGESTIONS AND CONCLUSION CHAPTER 6 SUGGESTIONS AND CONCLUSION CHAPTER 6 SUGGESTIONS AND CONCLUSION From the basis of data analysis and inferences drawn the following suggestions are offered for the improvement of marketing Strategies

More information

<Insert Picture Here> Healthcare and Life Sciences Mission & Strategy. Leo Liang Vice President HSGBU Japan and APAC

<Insert Picture Here> Healthcare and Life Sciences Mission & Strategy. Leo Liang Vice President HSGBU Japan and APAC Healthcare and Life Sciences Mission & Strategy Leo Liang Vice President HSGBU Japan and APAC The following is intended to outline our general product direction. It is intended for

More information

Visiongain. -v1531/ Publisher Sample

Visiongain.   -v1531/ Publisher Sample Visiongain http://www.marketresearch.com/visiongain -v1531/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm EST Fridays:

More information

Jefferies 2018 Global Healthcare Conference. June 7, 2018

Jefferies 2018 Global Healthcare Conference. June 7, 2018 Jefferies 2018 Global Healthcare Conference June 7, 2018 Forward-Looking Statements Statements in this presentation regarding the future financial and operating results, outlook, growth, prospects, business

More information

GDUFA Past & Present

GDUFA Past & Present GDUFA Past & Present David R. Gaugh, R.Ph. Senior Vice President for Sciences and Regulatory Affairs Generic Pharmaceutical Association June 15, 2015 About GPhA GPhA represents the manufacturers and distributors

More information

FEBRUARY 2015 D. Lee Spurgin, Jr., PhD

FEBRUARY 2015 D. Lee Spurgin, Jr., PhD FEBRUARY 2015 D. Lee Spurgin, Jr., PhD Resources - Publications Little Advisor ICH-GCP, Investigational Site - English Little Advisor ISO 14155:2011, Sponsor Responsibilities - English Little Advisor ISO

More information

TCS Financial Results

TCS Financial Results TCS Financial Results Quarter I FY 2017-18 July 13, 2017 1 Copyright 2017 Tata Consultancy Services Limited Disclaimer Certain statements in this release concerning our future prospects are forward-looking

More information

I N D U S T R Y O U T L O O K D E C E M B E R

I N D U S T R Y O U T L O O K D E C E M B E R INDUSTRY OUTLOOK DECEMBER 2012 Shifting Sands: Semiconductor Makers Face New Challenges as Momentum Moves from Developed Economies to Emerging Markets Changing consumer preferences and buying habits for

More information

Information Management and Business Intelligence. Service brochure

Information Management and Business Intelligence. Service brochure Information Management and Business Intelligence Service brochure Organizations increasingly recognize information as a business asset. However, there has been very little attempt to exploit information

More information

Using local RWD to drive global therapeutic advancements.

Using local RWD to drive global therapeutic advancements. Using local RWD to drive global therapeutic advancements. Helsinki, 30 th Nov 2016 Mike Spencer, Head of Real World Evidence, EMEA, Janssen The following represent my own views and not necessarily those

More information

WINNING BRAND VS. GENERIC COMPETITION

WINNING BRAND VS. GENERIC COMPETITION WINNING BRAND VS. GENERIC COMPETITION - Competition 2.0: Brands vs. Generics - Winning Beyond the Molecule www.bernardassociatesllc.com Innovator and generic companies are colliding as they invade each

More information

Artificial Intelligence in Life Sciences: The Formula for Pharma Success Across the Drug Lifecycle

Artificial Intelligence in Life Sciences: The Formula for Pharma Success Across the Drug Lifecycle Volume XX, Issue 60 Artificial Intelligence in Life Sciences: The Formula for Pharma Success Across the Drug Lifecycle Artificial intelligence (AI) has the potential to transform the pharmaceutical industry.

More information

An Economic Analysis of Generic Drug Usage in the U.S.

An Economic Analysis of Generic Drug Usage in the U.S. September 2011 $931 Billion SAVINGS An Economic Analysis of Generic Drug Usage in the U.S. EXECUTIVE SUMMARY As government leaders in Washington and across the country look for ways to cut health care

More information

PHARMA MARKET REPORT- UGANADA

PHARMA MARKET REPORT- UGANADA PHARMA MARKET REPORT- UGANADA PHARMEXCIL Hyderabad Contents DEMOGRAPHY...1 Introduction...2 Latest Updates...3 Strengths...3 Weaknesses...3 Opportunities...3 Market...3 Regulations:...4 Epidemiology...4

More information

INDUSTRY OVERVIEW BIOLOGICS MARKET GLOBALLY AND IN CHINA. Definition of Biologics

INDUSTRY OVERVIEW BIOLOGICS MARKET GLOBALLY AND IN CHINA. Definition of Biologics Certain information and statistics set out in this section and elsewhere in this Document relating to the industry in which we operate are derived from the industry report prepared by Frost & Sullivan,

More information

NEXT BIG WAVE IN PHARMACEUTICAL INDUSTRY

NEXT BIG WAVE IN PHARMACEUTICAL INDUSTRY SEPTEMBER 15, 2017 NEXT BIG WAVE IN PHARMACEUTICAL INDUSTRY Team Mavericks Smriti Mittal Pamela Mandal Harendra Prasad IIM Bangalore IIM Bangalore IIM Bangalore Smriti.mittal16@iimb.ernet.in pamela.mandal16@iimb.ernet.in

More information

Jefferies 2017 Global Healthcare Conference. June 7, 2017

Jefferies 2017 Global Healthcare Conference. June 7, 2017 Jefferies 2017 Global Healthcare Conference June 7, 2017 Forward-Looking Statements This document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act

More information

Before proceeding to the formal part of today s meeting, I wanted to take this opportunity to say a few words about your Company.

Before proceeding to the formal part of today s meeting, I wanted to take this opportunity to say a few words about your Company. AstraZeneca 2011 AGM 28 April 2011 Chairman s remarks Before proceeding to the formal part of today s meeting, I wanted to take this opportunity to say a few words about your Company. 2010 AstraZeneca

More information

General issues. Rational Drug Design lecture 1

General issues. Rational Drug Design lecture 1 Rational Drug Design lecture 1 Łukasz Berlicki General issues E-mail: lukasz.berlicki@pwr.edu.pl consultations: room 322a/A2, Monday, Thursday, 11-12 AM TEST, January 22 nd, 3.15PM Additional tests: 25.01-12.02

More information